This move is archived. Current quotes and coverage live on the stock page.
Get AVCN alerts:
Avicanna Inc (AVCN.TO) faces a challenging day on the TSX, with shares down 3.57%.
Avicanna Inc, a biopharmaceutical company specializing in cannabinoid-based products, is seeing its stock price decline, closing at CA$0.14 after a 3.57% drop in the last trading session. This decline comes amid significant corporate developments, including recent investments and private placements that were expected to improve its financial situation.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$14.78M
52W high
$0.30
52W low
$0.10
1W change
-4.17%
Beta
0.34
Analyst Price Targets
Based on analyst covering AVCN
Wall Street analysts forecast AVCN stock price to rise 508.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+508.7% Upside
Current Price
C$0.12
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
95.0%
Annualized
90-Day Vol
79.0%
Annualized
Trend (90d)
-35.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.11 | C$0.08 – C$0.15 |
| 60 trading days | C$0.11 | C$0.07 – C$0.17 |
| 90 trading days | C$0.10 | C$0.06 – C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Avicanna's recent price drop may indicate underlying concerns despite ongoing strategic partnerships and capital raises.
Avicanna Inc sees a 3.57% drop in stock price
The stock's decline reflects broader market concerns and investor sentiment towards the cannabis sector, which remains volatile and uncertain.
Bull case
The recent CDN$300,000 investment from Splash Beverage Group shows confidence in Avicanna's potential in the evolving cannabinoid healthcare market. With a strong product pipeline and established market presence, the company could bounce back as it capitalizes on its clinical development efforts.
Bear case
Despite these strategic investments, Avicanna's stock performance suggests that investors are skeptical. This skepticism may stem from ongoing market volatility in the cannabis sector and the company's negative profit margin. The company's reliance on future developments to drive growth could be risky if it fails to meet anticipated milestones.
Market Reaction to Avicanna's Performance
Advertisement
Avicanna's stock price drop of 3.57% signals investor apprehension, particularly given the company's ongoing challenges in maintaining profitability. The market capitalization now stands at approximately CA$15.7 million, reflecting concerns about the sustainability of its business model in a competitive landscape.
Recent Developments and Strategic Partnerships
The recent CDN$300,000 investment from Splash Beverage Group is a notable development for Avicanna, aimed at strengthening its position in the cannabinoid healthcare sector. While this investment may provide short-term capital, the long-term impact on share performance remains uncertain, especially considering the company's negative profit margin of -12.09%.
Looking Ahead: What Investors Should Consider
Investors should keep an eye on Avicanna's upcoming announcements and product developments. The company's ability to leverage its strategic partnerships and clinical programs will be crucial in determining its recovery trajectory in the stock market. As always, potential investors should weigh the risks associated with volatility in the cannabis sector against the company's growth prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
